Arbutus Biopharma ABUS
NASDAQ ABUS
$4.69 -0.17 (-3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Operating Expenses (2013 - 2026)

Updated

Arbutus Biopharma's Operating Expenses was $6.98 million in Q2 2026, down 24.6% from $9.25 million a year earlier and down 31.7% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Operating Expenses (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arbutus Biopharma's Operating Expenses was $32.73 million through Jun 30, 2026, down 56.4% year-over-year; for FY2025, it was $52.24 million, down 36.7% from FY2024.

  • Operating Expenses has now declined for three consecutive years, with a five-year compound annual growth rate of -4.2% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $82.49 million in FY2024 (-14.3%), $96.24 million in FY2023 (-7.9%), $104.48 million in FY2022 (+23.6%) and $84.51 million in FY2021 (+30.6%).
  • Quarterly Operating Expenses has moved between $6.34 million (Q4 2025) and $28.81 million (Q4 2022) over five years.
  • Compared with a year earlier, Operating Expenses has declined for five straight quarters, with an average decline of 35.0% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q2 2022 (growth of 35.2%); the worst was Q1 2026 (a decline of 62.8%).
  • Per Business Quant data, ABUS's Operating Expenses in the three quarters before Q2 2026 was $10.22 million (Q1 2026), $6.34 million (Q4 2025) and $9.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Arbutus Biopharma 960.50 Mn 587.48 Mn - 6.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.98 Mn
Mar 31, 2026 10.22 Mn
Dec 31, 2025 6.34 Mn
Sep 30, 2025 9.19 Mn
Jun 30, 2025 9.25 Mn
Mar 31, 2025 27.46 Mn
Dec 31, 2024 15.51 Mn
Sep 30, 2024 22.78 Mn
Jun 30, 2024 23.31 Mn
Mar 31, 2024 20.90 Mn
Dec 31, 2023 22.89 Mn
Sep 30, 2023 26.22 Mn
Jun 30, 2023 23.04 Mn
Mar 31, 2023 24.10 Mn
Dec 31, 2022 28.81 Mn
Sep 30, 2022 23.76 Mn
Jun 30, 2022 28.35 Mn
Mar 31, 2022 23.56 Mn
Dec 31, 2021 24.00 Mn
Sep 30, 2021 21.75 Mn
API Access

Arbutus Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ABUS&period=max&api_key=YOUR_API_KEY